Reconsidering low HDL-cholesterol levels as a predictive factor for the development of hepatocellular carcinoma
JHEP Rep
.
2023 Apr 6;5(8):100752.
doi: 10.1016/j.jhepr.2023.100752.
eCollection 2023 Aug.
Authors
Hideki Fujii
1
,
Hirokazu Takahashi
2
,
Yoshihiro Kamada
3
,
Yoshio Sumida
4
,
Atsushi Nakajima
5
Affiliations
1
Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
2
Liver Center, Saga University Hospital, Saga, Japan.
3
Department of Advanced Metabolic Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
4
Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan.
5
Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
PMID:
37554923
PMCID:
PMC10405084
DOI:
10.1016/j.jhepr.2023.100752
No abstract available